Corvia Medical, Inc. announced that it has received $54 million in funding from Accelmed Partners, Lumira Ventures, General Catalyst Group Management, LLC, Third Rock Ventures, LLC, Edwards Lifesciences Corporation, and other investors

On June 9, 2022, Corvia Medical, Inc. closed the transaction. The company has received $13,734,351.7076 in its third tranche bringing total funding raised in the transaction to $54,000,000. The round of funding from returning investors like General Catalyst Group Management, LLC, Edwards Lifesciences Corporation, Lumira Ventures, Third Rock Ventures, LLC and Accelmed Partners.